AirSculpt Technologies (NASDAQ:AIRS) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of AirSculpt Technologies (NASDAQ:AIRS) from a sell rating to a hold rating in a research report report published on Sunday.

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of AirSculpt Technologies in a research note on Monday, December 29th. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Reduce” and a consensus target price of $6.00.

AirSculpt Technologies Price Performance

Shares of NASDAQ:AIRS opened at $2.94 on Friday. The business has a 50 day moving average price of $2.34 and a 200 day moving average price of $4.29. AirSculpt Technologies has a twelve month low of $1.51 and a twelve month high of $12.00. The company has a market cap of $207.42 million, a price-to-earnings ratio of -15.47 and a beta of 2.22. The company has a quick ratio of 0.51, a current ratio of 0.51 and a debt-to-equity ratio of 0.63.

AirSculpt Technologies (NASDAQ:AIRS) last announced its earnings results on Tuesday, March 31st. The company reported $0.02 earnings per share for the quarter, beating the consensus estimate of ($0.03) by $0.05. AirSculpt Technologies had a negative return on equity of 14.30% and a negative net margin of 11.41%.The firm had revenue of $33.44 million during the quarter, compared to the consensus estimate of $34.93 million. During the same quarter in the prior year, the company earned ($0.09) EPS. The firm’s revenue for the quarter was down 14.8% compared to the same quarter last year. Research analysts predict that AirSculpt Technologies will post -0.01 earnings per share for the current year.

Insiders Place Their Bets

In other AirSculpt Technologies news, major shareholder Jorey Chernett purchased 90,000 shares of the firm’s stock in a transaction on Friday, April 3rd. The shares were purchased at an average price of $2.82 per share, for a total transaction of $253,800.00. Following the completion of the purchase, the insider directly owned 6,933,761 shares of the company’s stock, valued at approximately $19,553,206.02. This represents a 1.32% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders have acquired a total of 690,150 shares of company stock worth $1,658,224 in the last 90 days. 76.58% of the stock is owned by insiders.

Institutional Investors Weigh In On AirSculpt Technologies

Institutional investors have recently bought and sold shares of the business. Engineers Gate Manager LP bought a new position in shares of AirSculpt Technologies during the fourth quarter valued at $54,000. BNP Paribas Financial Markets lifted its holdings in shares of AirSculpt Technologies by 239.5% during the third quarter. BNP Paribas Financial Markets now owns 5,952 shares of the company’s stock valued at $48,000 after acquiring an additional 4,199 shares during the period. Aigen Investment Management LP bought a new position in shares of AirSculpt Technologies during the fourth quarter valued at $36,000. Millennium Management LLC bought a new position in shares of AirSculpt Technologies during the fourth quarter valued at $33,000. Finally, Virtu Financial LLC bought a new position in shares of AirSculpt Technologies during the fourth quarter valued at $30,000. Institutional investors and hedge funds own 91.54% of the company’s stock.

AirSculpt Technologies Company Profile

AirSculpt Technologies, Inc (NASDAQ: AIRS) is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.

Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.